Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.

Zijian DaLong GaoGang SuJia YaoWenkang FuJinduo ZhangXu ZhangZhaoji PeiPing YueBing BaiYanyan LinWenbo MengXun Li

Published in: Cancer cell international (2020)

CASK may be a tumour suppressor; its low expression is an independent risk factor for a poor prognosis in CCA patients, and so it could be used as a clinically valuable prognostic marker.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
mass spectrometry